RxDoctor Payments Data

Fritz-Andre Duterlien, DPM

Podiatrist · Baltimore, MDNPI 1780200303

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (55.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Supreme Orthopedic Systems, LLC accounts for 61.2% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2021 at $2,587 and has fallen 87.9% since, to $313 in 2025. Among podiatrist clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,047in general payments, 2019–2025

Across 57 payments — averaging $158.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supreme Orthopedic Systems, LLC$6K
  • Orthofix Medical, Inc.$2K
  • Smith+Nephew$366
  • Arthrex$333
  • Averitas Pharma Inc.$175
  • Nuvasive Specialized Orthopedics, Inc.$164
  • plus $436 from 7 others

What the payments were for

  • Travel & lodging$2,35626%
  • Food & beverage$1,71419%
  • Education$4,97755%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,047 in reported general payments places this provider in the 90th percentile of 183 podiatrist providers in Maryland.

See all podiatrist providers in Maryland

Medicare billing

Part B allowed, 2024
$48,981
Medicare patients
149
Services billed
563

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JubliaEfinaconazole37$53,787
Ketoconazole436$11,915
Ammonium Lactate188$5,888
Diclofenac Sodium15$467
Etodolac15$337

Paid to pharmacies, not to this prescriber.

Other podiatrist in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →